Elacridar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
This study was designed to investigate the effects of P-glycoprotein (P-gp) expressed in the intestine on the nonlinear…
In the past years, the development of oral formulations of the taxane anticancer drugs paclitaxel (Taxol®) and docetaxel…
Tariquidar and elacridar are among the most potent inhibitors of the multidrug resistance transporter P‐glycoprotein (P‐gp), but…
Although the CB1 receptor antagonist/inverse agonist rimonabant has positive effects on weight loss and cardiometabolic risk…
P-glycoprotein (P-gp) is involved in MDR and in neurodegenerative disorders such as Parkinson disease (PD), Alzheimer disease (AD…
textabstractImatinib mesylate, the first tyrosine kinase inhibitor to gain approval by the FDA,
remains as a pivotal example of…